Specific Binding Agents for KSHV vIL-6 That Neutralize a Biological Activity
US Patent 7,374,756
Filed on 2007-05-14
Filed on 2007-05-14
INHIBITION OF CELL MOTILITY AND ANGIOGENESIS BY INHIBITORS OF THE GRB2 SH2-DOMAIN
Italy
00992431.7
Filed on 2000-10-20
00992431.7
Filed on 2000-10-20
INHIBITION OF CELL MOTILITY AND ANGIOGENESIS BY INHIBITORS OF THE GRB2 SH2-DOMAIN
United Kingdom
00992431.7
Filed on 2000-10-20
00992431.7
Filed on 2000-10-20
INHIBITION OF CELL MOTILITY AND ANGIOGENESIS BY INHIBITORS OF THE GRB2 SH2-DOMAIN
France
00992431.7
Filed on 2000-10-20
00992431.7
Filed on 2000-10-20
INHIBITION OF CELL MOTILITY AND ANGIOGENESIS BY INHIBITORS OF THE GRB2 SH2-DOMAIN
Spain
00992431.7
Filed on 2000-10-20
00992431.7
Filed on 2000-10-20
INHIBITION OF CELL MOTILITY AND ANGIOGENESIS BY INHIBITORS OF THE GRB2 SH2-DOMAIN
Germany
00992431.7
Filed on 2000-10-20
00992431.7
Filed on 2000-10-20
INHIBITION OF CELL MOTILITY AND ANGIOGENESIS BY INHIBITORS OF THE GRB2 SH2-DOMAIN
Switzerland
00992431.7
Filed on 2000-10-20
00992431.7
Filed on 2000-10-20
Adoptive Immunotherapy with Enhanced T Lymphocyte Survival
European Patent
05858553.0
Filed on 2005-10-07
05858553.0
Filed on 2005-10-07
Adoptive Immunotherapy with Enhanced T Lymphocyte Survival
Australia
2005336093
Filed on 2005-10-07
2005336093
Filed on 2005-10-07
Adoptive Immunotherapy with Enhanced T Lymphocyte Survival
Canada
2590401
Filed on 2010-10-07
2590401
Filed on 2010-10-07